申请人:YM Biosciences Australia Pty Ltd.
公开号:US20140221396A1
公开(公告)日:2014-08-07
Compounds of general formula (I), (II), (III) and (V) are described for use in modulating microtubule polymerisation and in the treatment of associated disease states. Use of compounds (I), (III) and (V) in the treatment of kinase-associated disease states is also described. Further described are novel compounds of formula (II), (III) and (V).
本发明描述了通式(I),(II),(III)和(V)的化合物,用于调节微管聚合和治疗相关疾病状态。还描述了在治疗激酶相关疾病状态中使用化合物(I),(III)和(V)。进一步描述了通式(II),(III)和(V)的新化合物。